Skip to content

Effect of Two Different Doses of Magnesium sulphate as Adjuvant to Ropivacaine in peribulbar block for cataract surgery

Effect of Two Different Doses of Magnesium sulphate as Adjuvant to Ropivacaine in peribulbar block for cataract surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201608001711322
Enrollment
105
Registered
2016-07-10
Start date
2016-06-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases Surgery cataract surgery Anaesthesia

Interventions

Group I (Control group)
Group II (Mg 50)
Group III (Mg100)

Sponsors

Tanta Univercity hospital anaesthesia department
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were eligible for inclusion if they were ASA I¿III and undergoing routine cataract extraction surgery in Tanta University Hospital

Exclusion criteria

Exclusion criteria: communication or language problems, history of allergy to amide local anaesthetic agents or hyaluronidase, known anatomical abnormalities or pre-existing extra-ocular muscle palsy., severe systemic disease, active ocular infection, single eye, who were pregnant, coagulopathy or those taking anti-coagulants, anti-epileptic drugs, anti-psychotic medication, anti-glaucoma drugs, atrioventricular block, , and obstructive apnea

Design outcomes

Primary

MeasureTime frame
akinesia score of the occular muscels ;duration sensory and motor block

Secondary

MeasureTime frame
total volume of local anesthetic

Countries

Egypt

Contacts

Public ContactMona Mogahed

Lecturer of Anesthesia and Surgical Intensive Care, Faculty of Medicine Tanta University

monamogahedfr@hotmail.com00201145130150

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026